NEW YORK, Nov. 7 — Two genomics companies separately on Wednesday announced strides forward in identifying disease-linked genes. 

Iceland’s deCODE genetics said it had filed patent applications on 350 genes discovered through its population genomics database, and Interleukin Genetics, of Waltham, Mass., said it has discovered 89 novel SNPs not previously identified in public databases.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.